Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Siren Siren +24.49%
#3 Ankr Network Ankr Network +22.99%
#4 BankrCoin BankrCoin +19.64%
#5 Pons Pons +15.53%
#6 Status Status +11.66%
#7 Wiki Cat Wiki Cat +8.87%
#8 RedStone RedStone +8.25%
#9 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.24%
#10 Hive Hive +7.22%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
Cabio Biotech (Wuhan) Co., Ltd. Cabio Biotech (Wuhan) Co., Ltd.

Cabio Biotech (Wuhan) Co., Ltd.

688089
Rank in Stocks #18132
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development,... Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.
Share Price
$1.26
Last synced: 2026-09-02
Market Cap
$211.46M
Change (1 day)
2.60%
Change (1 year)
-66.15%
Country
CN
Trade Cabio Biotech (Wuhan) Co., Ltd. (688089)

Category

Healthcare
Earnings for Cabio Biotech (Wuhan) Co., Ltd. (688089)
Earnings in 2026 TTM: 0
According to Cabio Biotech (Wuhan) Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Cabio Biotech (Wuhan) Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH